As of Feb 12
| -2.70 / -6.46%|
The 16 analysts offering 12-month price forecasts for NuVasive Inc have a median target of 55.00, with a high estimate of 63.00 and a low estimate of 47.00. The median estimate represents a +40.59% increase from the last price of 39.12.
The current consensus among 21 polled investment analysts is to Buy stock in NuVasive Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.